|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 52.23 USD | -1.53% |
|
52.66 | +0.81% |
| Market Cap | 7.82TCr 11TCr 9.05TCr 8.33TCr 15TCr 9,92700Cr 15TCr 98TCr 38TCr 4,86100Cr 39TCr 39TCr 16,82100Cr | P/E Ratio 2026 * |
12.6x | P/E Ratio 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 9.24TCr 12TCr 11TCr 9.85TCr 17TCr 11,73700Cr 18TCr 1,16500Cr 45TCr 5,74800Cr 47TCr 46TCr 19,88800Cr | EV / Sales 2026 * |
2.74x | EV / Sales 2027 * | 2.52x |
| Free-Float |
92.3% | Yield 2026 * |
3.58% | Yield 2027 * | 3.74% |
Last Transcript: GSK plc
| 1 day | -1.53% | ||
| 1 week | +3.14% | ||
| Current month | +3.34% | ||
| 1 month | +5.15% | ||
| 3 months | -2.17% | ||
| 6 months | +6.07% | ||
| Current year | +6.50% |
| 1 week | 50.98 |  | 53.45 |
| 1 month | 48.57 | | 53.45 |
| Current year | 47.62 | | 61.7 |
| 1 year | 35.45 | | 61.7 |
| 3 years | 31.72 | | 61.7 |
| 5 years | 28.46 | | 61.7 |
| 10 years | 28.46 | | 61.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53% | +3.14% | - | - | 11TCr | |
| -0.32% | -1.72% | +37.83% | +148.79% | 1,01000Cr | |
| -2.16% | +1.51% | +50.01% | +43.93% | 58TCr | |
| -2.70% | -0.66% | +15.97% | +63.07% | 40TCr | |
| -1.18% | +1.05% | +20.91% | +18.37% | 33TCr | |
| -1.52% | +2.45% | +23.73% | +33.03% | 28TCr | |
| -1.95% | -4.32% | +20.15% | +12.96% | 28TCr | |
| -0.57% | +5.00% | -44.67% | -48.28% | 20TCr | |
| -1.31% | +1.39% | +18.74% | +53.45% | 19TCr | |
| -0.38% | -2.97% | +13.02% | +57.34% | 16TCr | |
| Average | -1.27% | +0.02% | +17.30% | +42.52% | 38.1TCr | |
| Weighted average by Cap. | -1.04% | -0.16% | +26.16% | +67.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38TCr 4.54TCr 3.91TCr 3.6TCr 6.35TCr 4,29100Cr 6.41TCr 43TCr 17TCr 2,10100Cr 17TCr 17TCr 7,27100Cr | 3.55TCr 4.77TCr 4.11TCr 3.78TCr 6.66TCr 4,50600Cr 6.73TCr 45TCr 17TCr 2,20600Cr 18TCr 18TCr 7,63500Cr |
| Net income | 626.62Cr 842.07Cr 725.78Cr 667.96Cr 1.18TCr 80TCr 1.19TCr 7.9TCr 3.08TCr 39TCr 3.16TCr 3.09TCr 1,34900Cr | 666.92Cr 896.22Cr 772.45Cr 710.92Cr 1.25TCr 85TCr 1.27TCr 8.4TCr 3.28TCr 41TCr 3.36TCr 3.29TCr 1,43500Cr |
| Net Debt | 1.43TCr 1.92TCr 1.65TCr 1.52TCr 2.68TCr 1,81000Cr 2.7TCr 18TCr 7.02TCr 89TCr 7.19TCr 7.03TCr 3,06700Cr | 1.12TCr 1.5TCr 1.3TCr 1.19TCr 2.1TCr 1,42100Cr 2.12TCr 14TCr 5.51TCr 70TCr 5.64TCr 5.52TCr 2,40800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | 52.23 $ | -1.53% | 34,34,088 |
| 12/26/12 | 53.04 $ | +0.34% | 38,05,968 |
| 11/26/11 | 52.86 $ | +3.30% | 50,18,503 |
| 10/26/10 | 51.17 $ | -0.16% | 50,76,049 |
| 09/26/09 | 51.25 $ | +1.20% | 61,15,445 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
